Systems-based Practice

TOLAC Risk Issues

TOLAC is defined as a trial of labor after one or more cesarean deliveries intended to result in a vaginal birth instead of a scheduled repeat Cesarean Section. Successful vaginal birth after Cesarean (VBAC) rates in TOLAC patients are reported…

Labor Induction-Module 7: Oxytocin Safe Administration

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 6: Oxytocin Pharmacodynamics

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 5: Misoprostol

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 4: Mechanical Methods

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 3: Cervical Ripening

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 1: Verdicts, Settlements, and a Case Study

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Opioid Use Disorder

Prescribing healthcare practitioners and patients with opioid use disorder (OUD) often have different perspectives. As a practitioner, you may face challenges in working with these patients. The patients themselves encounter barriers and difficulties associated with getting the treatments they need….